4.7 Article

Brain β-amyloid load approaches a plateau

Journal

NEUROLOGY
Volume 80, Issue 10, Pages 890-896

Publisher

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1212/WNL.0b013e3182840bbe

Keywords

-

Funding

  1. Allon
  2. Baxter, Inc.
  3. NIH [R01-AG011378, RO1-AG037551, U01-HL096917, U01-AG032438, U01-AG024904, R01AG040042, U01AG06786]
  4. Mayo Foundation
  5. Janssen Pharmaceuticals
  6. NIH (Mayo Clinic Alzheimer's Disease Research Center/Core) [P50AG16574, R01AG32990]
  7. GE Healthcare
  8. Siemens Molecular Imaging
  9. NIH (NIA, NCI),
  10. MN Partnership for Biotechnology and Medical Genomics
  11. Leukemia & Lymphoma Society
  12. Behavioral Neurology of Dementia (Cambridge University Press)
  13. Cephalon, Inc.
  14. Allon Therapeutics, Inc.
  15. NIH/NIA
  16. Alzheimer's Association
  17. Mangurian Foundation
  18. Elan Pharmaceuticals
  19. Oxford University Press

Ask authors/readers for more resources

Objective: To model the temporal trajectory of beta-amyloid accumulation using serial amyloid PET imaging. Methods: Participants, aged 70-92 years, were enrolled in either the Mayo Clinic Study of Aging (n = 246) or the Mayo Alzheimer's Disease Research Center (n = 14). All underwent 2 or more serial amyloid PET examinations. There were 205 participants classified as cognitively normal and 55 as cognitively impaired (47 mild cognitive impairment and 8 Alzheimer dementia). We measured baseline amyloid PET-relative standardized uptake values (SUVR) and, for each participant, estimated a slope representing their annual amyloid accumulation rate. We then fit regression models to predict the rate of amyloid accumulation given baseline amyloid SUVR, and evaluated age, sex, clinical group, and APOE as covariates. Finally, we integrated the amyloid accumulation rate vs baseline amyloid PET SUVR association to an amyloid PET SUVR vs time association. Results: Rates of amyloid accumulation were low at low baseline SUVR. Rates increased to a maximum at baseline SUVR around 2.0, above which rates declined-reaching zero at baseline SUVR above 2.7. The rate of amyloid accumulation as a function of baseline SUVR had an inverted U shape. Integration produced a sigmoid curve relating amyloid PET SUVR to time. The average estimated time required to travel from an SUVR of 1.5-2.5 is approximately 15 years. Conclusion: This roughly 15-year interval where the slope of the amyloid SUVR vs time curve is greatest and roughly linear represents a large therapeutic window for secondary preventive interventions. Neurology (R) 2013;80:890-896

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available